Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease – a combined tissue microarray, in vitro and in vivo study

Figure 1

mTOR activity is increased in lymphoma cells. mTOR activity related phosphoproteins in different lymphomas detected by IHC. Lymphomas with high mTOR activity (2+/3+): Hodgkin-lymphoma (A-D), mantle cell lymphoma (E), Burkitt-lymphoma (F-G), diffuse large B-cell lymphoma (H), anaplastic large-cell lymphoma (I). Lymphomas with low mTOR activity (0/1+) comparable to non malignant lymphoid cells: chronic lymphoid leukemia/small lymphocytic lymphoma (J), marginal zone lymphoma (K); control lymph node (L); (IHC), 200X, 400X.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us